Oncology Clinical Trial Execs to Increase Decentralization, Science 37 Survey Indicates
June 15, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., June 15, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today published new data from oncology clinical...
Science 37® to Participate in Upcoming Investor Conferences
June 07, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., June 07, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating...
Science 37® to Present at the William Blair 42nd Annual Growth Stock Conference
May 25, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 25, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating...
Science 37 Introduces Virtual Site Model to Rescue Slow Enrolling Clinical Trials
May 12, 2022 16:01 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 12, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today introduced a rapid-deployment virtual site...
Science 37® Extends Leadership in Decentralized Clinical Trial Market with NextGen SaaS Release to Fully Orchestrate Decentralized Study Conduct
May 10, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today introduced a milestone technology release,...
Science 37 Reports First Quarter 2022 Financial Results
May 09, 2022 06:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 09, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
Science 37 to Report First Quarter 2022 Financial Results on May 9, 2022
April 25, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report first quarter...
Science 37® Adds Acclaimed Researcher and Oncologist, Dr. Shaalan Beg to Bolster Therapeutic Depth
March 31, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., March 31, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it is fortifying its oncology...
Science 37 Reports Fourth Quarter and Full Year 2021 Financial Results
March 22, 2022 07:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., March 22, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
Science 37 to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022
March 08, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., March 08, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report fourth quarter...